key: cord-0686751-z49n8yh7
authors: Yin, Wanchao; Xu, Youwei; Xu, Peiyu; Cao, Xiaodan; Wu, Canrong; Gu, Chunyin; He, Xinheng; Wang, Xiaoxi; Huang, Sijie; Yuan, Qingning; Wu, Kai; Hu, Wen; Huang, Zifu; Liu, Jia; Wang, Zongda; Jia, Fangfang; Xia, Kaiwen; Liu, Peipei; Wang, Xueping; Song, Bin; Zheng, Jie; Jiang, Hualiang; Cheng, Xi; Jiang, Yi; Deng, Su-Jun; Xu, H. Eric
title: Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody
date: 2022-02-08
journal: Science
DOI: 10.1126/science.abn8863
sha: f5d5ee02fccfc4f918bfe1a358124a2348b86b9f
doc_id: 686751
cord_uid: z49n8yh7

The SARS-CoV-2 Omicron variant has become the dominant infective strain. We report the structures of the Omicron spike trimer on its own or in complex with ACE2 or an anti-Omicron antibody. Most Omicron mutations are located on the surface of the spike protein, which change binding epitopes to many current antibodies. In the ACE2 binding site, compensating mutations strengthen RBD binding to ACE2. Both the RBD and the apo form of the Omicron spike trimer are thermodynamically unstable. An unusual RBD-RBD interaction in the ACE2-spike complex supports the open conformation and further reinforces ACE2 binding to the spike trimer. A broad-spectrum therapeutic antibody, JMB2002, which has completed a Phase 1 clinical trial, maintains neutralizing activity against Omicron. JMB2002 binds to RBD differently from other characterized antibodies and inhibits ACE2 binding.

For the Omicron spike ECD trimer protein only, the Omicron spike ECD protein was directedly set to purification by gel filtration chromatography using a Superose6 column (GE Healthcare) pre-equilibrated with TBS buffer (20 mM Tris, pH 8.0, 150 mM NaCl) or HBS buffer (25 mM HEPES, pH 7.5, 150 mM NaCl). Fractions containing the complex were pooled and concentrated to 1.5-3 mg/ml.

For the ACE2 bound Omicron spike ECD protein complex, 3 μL sample purified with TBS buffer at the concentration of 2.5 mg/ml were applied to glow-discharged 5 UltrAuFoil Holey Gold 300 mesh grids (Au, R1.2/1.3); For the JMB2002Fab bound Omicron spike ECD protein complex, 3 μL sample purified with HBS buffer at the concentration of 2.5 mg/ml were applied to glow-discharged 300 mesh amorphous NiTi foil (Au, 1.2/1.3). Extra samples were blotted with filter paper for 3.0 s and plunge-frozen in liquid ethane using a FEI Vitrobot Mark IV. Cryo-EM micrographs were collected on a 300kV Titan Krios microscope (FEI) equipped with a K3 direct detection camera.

For ECD-ACE2 dataset, 8,194 movies were collected, and for ECD-Fab dataset, 14,740 movies were collected on a Titan Krios equipped with a Gatan K3 direct electron detection device at 300kV with a magnification of 105,000, corresponding to a pixel size 0.824 Å. Image acquisition was performed with EPU Software (FEI Eindhoven, Netherlands). We collected a total of 36 frames accumulating to a total dose of 50 e -Å -2 over 2.5 s exposure.

For ECD-ACE2 dataset, MotionCor2 was used to perform the frame-based motioncorrection algorithm to generate drift-corrected micrograph for further processing and CTFFIND4 provided the estimation of the contrast transfer function (CTF) parameters (23, 24) . 1,566 aligned micrographs were deleted because of contaminations or bad ice quality. After selection, approximately 1,500 particles were manually picked and two-dimensional (2D) classes were calculated and used as references for automatic picking. A total of 5,071,668 particles were extracted from the cryo-EM micrographs performed with Relion3.0 (25) . All subsequent steps including 2D classification, three-dimensional (3D) classification, 3D refinement, and local refinement were performed using cryoSPARC (26) , unless stated otherwise.

Two rounds of reference-free 2D classification, yielding 854,875 particles after clearance. Three rounds hetero refinement separated out 522,186 particles that resulted to a clearer density of ECD-trimer structure at 2.56 Å global resolution. Two rounds hetero refinement separated out 242,374 particles that resulted to a clearer 6 density of ACE2 bound ECD-trimer structure at 2.77 Å global resolution. Local refinement focused on the ACE2-RBD or RBD-ACE2-RBD with masks could reconstitute ACE2-RBD and RBD-ACE2-RBD structures at 2.79 Å and 2.57 Å global resolution, respectively. Local resolution estimate was performed with cryoSPARC.

For ECD-Fab dataset, MotionCor2 was used to perform the frame-based motioncorrection algorithm to generate drift-corrected micrograph for further processing and CTFFIND4 provided the estimation of the contrast transfer function (CTF) parameters (23, 24) . Automated particle selection yielded 6,563,376 particles. Two rounds of reference-free 2D classification and three rounds hetero refinement separated out 172,001 particles that resulted to a density of ECD-trimer bound to 1 Fab at 3.18 Å global resolution, 906,588 particles that resulted a density of ECD-trimer bound to 2 Fab at 2.69 Å global resolution, and 434,893 particles that resulted to a density of ECD-trimer bound to 1 Fab at 2.92 Å global resolution. The maps were sharpened by DeepEMhancer (27) . Local resolution estimate was performed with cryoSPARC. For the structure of RBD-Fab interface, the particles of ECD-trimer bound 2 Fab were performed 3D classification focus on the RBD-Fab interface. Well-defined classes including 483,474 particles were performed local refinement, resulting a density map at 2.47 Å resolution.

ECD structure from Swiss-model prediction was used as the starting reference model for ECD-trimer building (28) . Structure of ACE2 derived from PDB entry 7KMB (29) was rigid body fit into the density. For the Fab-ECD complex, the structure of the SARS-CoV-2 spike glycoprotein (PDB: 6VXX(30)) and the Fab-nanobody-AMPK structure (PDB:7JHH(21)) were used as initial model. All models were fitted into the EM density map using UCSF Chimera(31) followed by iterative rounds of manual adjustment and automated rebuilding in COOT (32) and PHENIX (33) , respectively.

The model was finalized by rebuilding in ISOLDE(34) followed by refinement in 7 PHENIX with torsion-angle restraints to the input model. The final model statistics were validated using Comprehensive validation (cryo-EM) in PHENIX (33) . All structural figures were prepared using Chimera (31) , Chimera X (35) , and PyMOL (Schrödinger, LLC.).

The spike ECD and RBD proteins of Omicron and WT SARS-CoV-2 were diluted to 

The binding of human ACE2 to Omicron and WT spike RBD/ECD were performed using Octet Red96e (Sartorius). The biotinylation of SARS-CoV-2 spike RBD or monomeric human ACE2 protein were carried out by using EZ-Link Sulfo-NHS-LC-Biotin kit (ThermoFisher Scientific, A39257) following the manufacturer's instruction. 

The interaction of anti-SARS-CoV-2 antibody JMB2002 with Omicron and WT spike ECD was determined using Octet Red96e (Sartorius). SA biosensors (Sartorius, 18-5020) were used to capture the biotinylated WT SARS-CoV-2 spike ECD protein 

The JMB2002 ability to block ACE2 binding Omicron spike trimer was assessed by luminescence based AlphaScreen technology (PerkinElmer) using a hexahistidine detection kit (36) . 10 nM ACE2 were attached to streptavidin-coated donor beads, and 10 nM His6-tagged Omicron spike ECD were attached to nickel-chelated acceptor beads. Donor beads contain a photosensitizer that, upon activation at 680 nm, converts ambient oxygen into singlet oxygen. When the acceptor beads are brought into close proximity of the donor beads by ACE2-Omicron spike ECD interaction, energy is transferred from singlet oxygen to thioxene derivatives in the acceptor beads, resulting in light emission at 520 to 620 nm. The binding mixtures, containing the indicated amounts of ACE2 and Omicron spike ECD and streptavidincoated donor beads (5mg/ml) and Ni-chelate-coated acceptor beads, were incubated in 50 mM Mops (pH 7.4), 100 mM NaCl, and bovine serum albumin (0.1 mg/ml) for 1 to 2 hours before data collection using an EnVision plate reader (PerkinElmer). (ThermoFisher) for high confident peptide identification. 11 The HDX data from all overlapping peptides were consolidated to individual amino acid values using a residue averaging approach. Briefly, for each residue, the deuterium incorporation values and peptide lengths from all overlapping peptides were assembled. A weighting function was applied in which shorter peptides were weighted more heavily and longer peptides were weighted less. Each of the weighted deuterium incorporation values were then averaged to produce a single value for each amino acid. The initial two residues of each peptide, as well as prolines, were omitted from the calculations. 

Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants

Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Stabilizing the closed SARS-CoV-2 spike trimer

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Structural and functional basis of SARS-CoV-2 entry by using human ACE2

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein

A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351

Structure of an AMPK complex in an inactive, ATP-bound state

Current status of therapeutic monoclonal antibodies against SARS-CoV-2

MotionCor2: Anisotropic correction of beam-induced motion for improved cryo-electron microscopy

CTFFIND4: Fast and accurate defocus estimation from electron micrographs

New tools for automated high-resolution cryo-EM structure determination in RELION-3

cryoSPARC: Algorithms for rapid unsupervised cryo-EM structure determination

DeepEMhancer: A deep learning solution for cryo-EM volume post-processing

SWISS-MODEL: An automated protein homology-modeling server

Cryo-EM structures of SARS-CoV-2 Spike without and with ACE2 reveal a pH-dependent switch to mediate endosomal positioning of receptorbinding domains

Structure, function, and antigenicity of the SARS-CoV-2 Spike glycoprotein

UCSF Chimera--A visualization system for exploratory research and analysis

Coot: Model-building tools for molecular graphics

Recent developments in the PHENIX software for automated crystallographic structure determination

ISOLDE: A physically realistic environment for model building into low-resolution electron-density maps

Structure visualization for researchers, educators, and developers

A gate-latch-lock mechanism for hormone signalling by abscisic acid receptors